Ribosomal protein L7a pseudogene 72 (RPL7AP72)

RPL7AP72 is a *processed pseudogene* of the ribosomal protein L7a gene (RPL7A). Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional due to mutations that prevent their expression or the production of a functional protein. RPL7AP72 is cataloged in several gene databases, such as NCBI Gene (100270754) and Ensembl (ENSG00000235735), but it does not encode a protein and has no known biological function, disease role, drug interactions, or biomarker status[4][8][11]. The canonical, functional gene *RPL7A* encodes the ribosomal protein L7a, a component of the ribosomal large (60S) subunit involved in protein synthesis[1][3]. However, RPL7AP72 is one of *multiple processed pseudogenes* scattered throughout the genome and does not produce a functional product[4][11]. No information exists indicating any known role for RPL7AP72 in disease, cell biology, or as a drug target[4][8]. Its classification as a pseudogene distinguishes it from molecular targets of pharmacological or therapeutic interest. RPL7AP72 is a pseudogene rather than a functional gene product or molecular target. There are no established biological functions, clinical roles, drug interactions, or safety concerns associated with this entity[4][8]. Therefore, it should not be considered a molecular target or therapeutic target.

Other names

RPL7A_34_1809RPL7AP72[4][8]